Anuh Pharma Ltd.
•₹ 76.030.16%
2026-08-21
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 21.8%
- Latest quarter profit grew 37.7% YoY, showing strong momentum
- Company has been maintaining a healthy dividend payout of 36.6%
- Company generates healthy free cash flow
- Company has a consistent dividend-paying track record
CONS
- Operating cash flow has been negative in recent years
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.32x)
- Company has delivered a poor profit growth of 7.6% over past five years
- Valuation is stretched - P/E of 16.4 is well above its own 5-year median (10.2)
- Operating margins have contracted to 7.4% from 10.9%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | ANUHPHR | 75.99 | 0.00 | 761.60 | 1.97 | 114.25 | 1276.51 | 1938.10 | 939.31 | 16.02 | 8.40 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 161 | 150 | 172 | 164 | 138 | 166 | 160 | 198 | 186 | 186 | 197 | 202 | 1,938 | |
| 148 | 132 | 148 | 145 | 127 | 149 | 145 | 179 | 176 | 174 | 180 | 182 | 1,800 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 3 | 2 | 4 | 3 | 4 | 3 | 1 | 1 | 3 | 1 | 4 | -1 | 31 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 24 |
| 15 | 18 | 25 | 20 | 12 | 18 | 13 | 17 | 11 | 10 | 18 | 16 | 169 | |
| Tax % | 23.75% | 22.60% | 24.46% | 22.11% | 22.49% | 17.32% | 22.00% | 27.89% | 24.20% | 23.29% | 24.57% | 24.74% | 32.51% |
| Net Profit | 12 | 14 | 19 | 15 | 10 | 15 | 10 | 12 | 8 | 8 | 13 | 12 | 114 |
| 2 | 3 | 4 | 3 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | |
| Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 50 | 50 | 50 | 501 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 50 | 50 | 50 | 501 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 161
- 148
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 2
- 15
- Tax %
- 23.75%
- Net Profit
- 12
- 2
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 150
- 132
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 2
- 18
- Tax %
- 22.60%
- Net Profit
- 14
- 3
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 172
- 148
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 2
- 25
- Tax %
- 24.46%
- Net Profit
- 19
- 4
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 164
- 145
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 2
- 20
- Tax %
- 22.11%
- Net Profit
- 15
- 3
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 138
- 127
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 2
- 12
- Tax %
- 22.49%
- Net Profit
- 10
- 2
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 166
- 149
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 2
- 18
- Tax %
- 17.32%
- Net Profit
- 15
- 2
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 160
- 145
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 2
- 13
- Tax %
- 22.00%
- Net Profit
- 10
- 1
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 198
- 179
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 3
- 17
- Tax %
- 27.89%
- Net Profit
- 12
- 1
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 186
- 176
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 11
- Tax %
- 24.20%
- Net Profit
- 8
- 2
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 186
- 174
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 3
- 10
- Tax %
- 23.29%
- Net Profit
- 8
- 1
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 197
- 180
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 3
- 18
- Tax %
- 24.57%
- Net Profit
- 13
- 1
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 202
- 182
- Operating Profit
- —
- OPM %
- —
- Other Income
- -1
- Interest
- 0
- Depreciation
- 3
- 16
- Tax %
- 24.74%
- Net Profit
- 12
- 1
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 1,938
- 1,800
- Operating Profit
- —
- OPM %
- —
- Other Income
- 31
- Interest
- 0
- Depreciation
- 24
- 169
- Tax %
- 32.51%
- Net Profit
- 114
- 1
- Equity Capital
- 501
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 501
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 206 | 238 | 321 | 307 | 432 | 487 | 527 | 647 | 662 | 772 | 779 | |
| 183 | 220 | 291 | 284 | 387 | 439 | 476 | 571 | 600 | 714 | 717 | |
| Operating Profit | 30 | 26 | 35 | 27 | 56 | 53 | 58 | 88 | 71 | 67 | — |
| OPM % | 15 | 11 | 11 | 9 | 13 | 11 | 11 | 14 | 11 | 9 | — |
| Other Income | 8 | 7 | 5 | 4 | 11 | 5 | 6 | 12 | 9 | 9 | 7 |
| Interest | 1 | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 2 | 2 | 2 | 7 | 15 | 12 | 10 | 9 | 9 | 11 | 11 |
| 28 | 23 | 32 | 19 | 39 | 39 | 47 | 78 | 61 | 54 | 60 | |
| Tax % | 27 | 29 | 28 | 25 | 26 | 22 | 24 | 23 | 22 | 24 | 27 |
| Net Profit | 20 | 17 | 23 | 14 | 28 | 31 | 36 | 60 | 47 | 41 | 44 |
| EPS | 0 | 0 | 0 | 0 | 6 | 6 | 7 | 12 | 9 | 4 | — |
| Dividend Payout % | 31 | 42 | 29 | 48 | 26 | 29 | 28 | 21 | 16 | 37 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 2 | 2 | 2 | 1 | 3 | 3 | 4 | 6 | 5 | 4 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 2 | 2 | 2 | 1 | 3 | 3 | 4 | 6 | 5 | 4 | — |
Mar 2017
- 206
- 183
- Operating Profit
- 30
- OPM %
- 15
- Other Income
- 8
- Interest
- 1
- Depreciation
- 2
- 28
- Tax %
- 27
- Net Profit
- 20
- EPS
- 0
- Dividend Payout %
- 31
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2018
- 238
- 220
- Operating Profit
- 26
- OPM %
- 11
- Other Income
- 7
- Interest
- 0
- Depreciation
- 2
- 23
- Tax %
- 29
- Net Profit
- 17
- EPS
- 0
- Dividend Payout %
- 42
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2019
- 321
- 291
- Operating Profit
- 35
- OPM %
- 11
- Other Income
- 5
- Interest
- 1
- Depreciation
- 2
- 32
- Tax %
- 28
- Net Profit
- 23
- EPS
- 0
- Dividend Payout %
- 29
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2020
- 307
- 284
- Operating Profit
- 27
- OPM %
- 9
- Other Income
- 4
- Interest
- 1
- Depreciation
- 7
- 19
- Tax %
- 25
- Net Profit
- 14
- EPS
- 0
- Dividend Payout %
- 48
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2021
- 432
- 387
- Operating Profit
- 56
- OPM %
- 13
- Other Income
- 11
- Interest
- 2
- Depreciation
- 15
- 39
- Tax %
- 26
- Net Profit
- 28
- EPS
- 6
- Dividend Payout %
- 26
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2022
- 487
- 439
- Operating Profit
- 53
- OPM %
- 11
- Other Income
- 5
- Interest
- 2
- Depreciation
- 12
- 39
- Tax %
- 22
- Net Profit
- 31
- EPS
- 6
- Dividend Payout %
- 29
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2023
- 527
- 476
- Operating Profit
- 58
- OPM %
- 11
- Other Income
- 6
- Interest
- 1
- Depreciation
- 10
- 47
- Tax %
- 24
- Net Profit
- 36
- EPS
- 7
- Dividend Payout %
- 28
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2024
- 647
- 571
- Operating Profit
- 88
- OPM %
- 14
- Other Income
- 12
- Interest
- 1
- Depreciation
- 9
- 78
- Tax %
- 23
- Net Profit
- 60
- EPS
- 12
- Dividend Payout %
- 21
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2025
- 662
- 600
- Operating Profit
- 71
- OPM %
- 11
- Other Income
- 9
- Interest
- 1
- Depreciation
- 9
- 61
- Tax %
- 22
- Net Profit
- 47
- EPS
- 9
- Dividend Payout %
- 16
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2026
- 772
- 714
- Operating Profit
- 67
- OPM %
- 9
- Other Income
- 9
- Interest
- 1
- Depreciation
- 11
- 54
- Tax %
- 24
- Net Profit
- 41
- EPS
- 4
- Dividend Payout %
- 37
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
TTM
- 779
- 717
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 0
- Depreciation
- 11
- 60
- Tax %
- 27
- Net Profit
- 44
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 9%
- 5 Years:
- 12%
- 3 Years:
- 14%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 5%
- 5 Years:
- 8%
- 3 Years:
- 4%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -17%
RETURN ON EQUITY
- 10 Years:
- 15%
- 5 Years:
- 16%
- 3 Years:
- 17%
- Last Year:
- 12%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 13 | 13 | 13 | 13 | 25 | 25 | 25 | 25 | 25 | 50 |
| 128 | 137 | 152 | 150 | 166 | 189 | 216 | 266 | 301 | 302 | |
| 0 | 2 | 4 | 45 | 14 | 3 | 0 | 2 | 10 | 0 | |
| Trade Payables | 42 | 52 | 59 | 105 | 120 | 122 | 153 | 141 | 157 | 188 |
| 5 | 4 | 11 | 15 | 8 | 9 | 10 | 12 | 11 | 14 | |
| Total Liabilities | 187 | 208 | 239 | 326 | 333 | 347 | 404 | 445 | 505 | 554 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 17 | 17 | 21 | 84 | 71 | 61 | 53 | 49 | 58 | 57 | |
| Capital Work in Progress | 0 | 6 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 70 | 66 | 39 | 80 | 31 | 43 | 91 | 97 | 106 | 84 | |
| 30 | 32 | 43 | 61 | 81 | 80 | 73 | 75 | 74 | 148 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 190 | 216 | 239 | |
| Cash & Bank | 6 | 8 | 11 | 3 | 20 | 16 | 7 | 8 | 20 | 8 |
| 63 | 79 | 91 | 99 | 128 | 147 | 181 | 25 | 30 | 18 | |
| Total Assets | 187 | 208 | 239 | 326 | 333 | 347 | 404 | 445 | 505 | 554 |
| Total Debt | 0 | 2 | 4 | 45 | 14 | 3 | 0 | 2 | 10 | 0 |
| Net Working Capital | 91 | 96 | 77 | 60 | 98 | 128 | 146 | 186 | 198 | 248 |
| Contingent Liabilities | 11 | 28 | 15 | 33 | 23 | 33 | 29 | 20 | 25 | 7 |
| Book Value per Share | 56.09 | 59.71 | 65.69 | 64.74 | 38.04 | 42.66 | 48.14 | 58.11 | 65.06 | 35.14 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Total Debt | 0 | 2 | 4 | 45 | 14 | 3 | 0 | 2 | 10 | 0 |
| Net Working Capital | 91 | 96 | 77 | 60 | 98 | 128 | 146 | 186 | 198 | 248 |
| Contingent Liabilities | 11 | 28 | 15 | 33 | 23 | 33 | 29 | 20 | 25 | 7 |
| Book Value per Share | 56.09 | 59.71 | 65.69 | 64.74 | 38.04 | 42.66 | 48.14 | 58.11 | 65.06 | 35.14 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Mar 2017
- Equity Capital
- 13
- 128
- 0
- Trade Payables
- 42
- 5
- Total Liabilities
- 187
- 17
- Capital Work in Progress
- 0
- 70
- 30
- 0
- Cash & Bank
- 6
- 63
- Total Assets
- 187
- Total Debt
- 0
- Net Working Capital
- 91
- Contingent Liabilities
- 11
- Book Value per Share
- 56.09
- Face Value
- 5.00
- Total Debt
- 0
- Net Working Capital
- 91
- Contingent Liabilities
- 11
- Book Value per Share
- 56.09
- Face Value
- 5.00
Mar 2018
- Equity Capital
- 13
- 137
- 2
- Trade Payables
- 52
- 4
- Total Liabilities
- 208
- 17
- Capital Work in Progress
- 6
- 66
- 32
- 0
- Cash & Bank
- 8
- 79
- Total Assets
- 208
- Total Debt
- 2
- Net Working Capital
- 96
- Contingent Liabilities
- 28
- Book Value per Share
- 59.71
- Face Value
- 5.00
- Total Debt
- 2
- Net Working Capital
- 96
- Contingent Liabilities
- 28
- Book Value per Share
- 59.71
- Face Value
- 5.00
Mar 2019
- Equity Capital
- 13
- 152
- 4
- Trade Payables
- 59
- 11
- Total Liabilities
- 239
- 21
- Capital Work in Progress
- 34
- 39
- 43
- 0
- Cash & Bank
- 11
- 91
- Total Assets
- 239
- Total Debt
- 4
- Net Working Capital
- 77
- Contingent Liabilities
- 15
- Book Value per Share
- 65.69
- Face Value
- 5.00
- Total Debt
- 4
- Net Working Capital
- 77
- Contingent Liabilities
- 15
- Book Value per Share
- 65.69
- Face Value
- 5.00
Mar 2020
- Equity Capital
- 13
- 150
- 45
- Trade Payables
- 105
- 15
- Total Liabilities
- 326
- 84
- Capital Work in Progress
- 0
- 80
- 61
- 0
- Cash & Bank
- 3
- 99
- Total Assets
- 326
- Total Debt
- 45
- Net Working Capital
- 60
- Contingent Liabilities
- 33
- Book Value per Share
- 64.74
- Face Value
- 5.00
- Total Debt
- 45
- Net Working Capital
- 60
- Contingent Liabilities
- 33
- Book Value per Share
- 64.74
- Face Value
- 5.00
Mar 2021
- Equity Capital
- 25
- 166
- 14
- Trade Payables
- 120
- 8
- Total Liabilities
- 333
- 71
- Capital Work in Progress
- 0
- 31
- 81
- 0
- Cash & Bank
- 20
- 128
- Total Assets
- 333
- Total Debt
- 14
- Net Working Capital
- 98
- Contingent Liabilities
- 23
- Book Value per Share
- 38.04
- Face Value
- 5.00
- Total Debt
- 14
- Net Working Capital
- 98
- Contingent Liabilities
- 23
- Book Value per Share
- 38.04
- Face Value
- 5.00
Mar 2022
- Equity Capital
- 25
- 189
- 3
- Trade Payables
- 122
- 9
- Total Liabilities
- 347
- 61
- Capital Work in Progress
- 0
- 43
- 80
- 0
- Cash & Bank
- 16
- 147
- Total Assets
- 347
- Total Debt
- 3
- Net Working Capital
- 128
- Contingent Liabilities
- 33
- Book Value per Share
- 42.66
- Face Value
- 5.00
- Total Debt
- 3
- Net Working Capital
- 128
- Contingent Liabilities
- 33
- Book Value per Share
- 42.66
- Face Value
- 5.00
Mar 2023
- Equity Capital
- 25
- 216
- 0
- Trade Payables
- 153
- 10
- Total Liabilities
- 404
- 53
- Capital Work in Progress
- 0
- 91
- 73
- 0
- Cash & Bank
- 7
- 181
- Total Assets
- 404
- Total Debt
- 0
- Net Working Capital
- 146
- Contingent Liabilities
- 29
- Book Value per Share
- 48.14
- Face Value
- 5.00
- Total Debt
- 0
- Net Working Capital
- 146
- Contingent Liabilities
- 29
- Book Value per Share
- 48.14
- Face Value
- 5.00
Mar 2024
- Equity Capital
- 25
- 266
- 2
- Trade Payables
- 141
- 12
- Total Liabilities
- 445
- 49
- Capital Work in Progress
- 0
- 97
- 75
- 190
- Cash & Bank
- 8
- 25
- Total Assets
- 445
- Total Debt
- 2
- Net Working Capital
- 186
- Contingent Liabilities
- 20
- Book Value per Share
- 58.11
- Face Value
- 5.00
- Total Debt
- 2
- Net Working Capital
- 186
- Contingent Liabilities
- 20
- Book Value per Share
- 58.11
- Face Value
- 5.00
Mar 2025
- Equity Capital
- 25
- 301
- 10
- Trade Payables
- 157
- 11
- Total Liabilities
- 505
- 58
- Capital Work in Progress
- 0
- 106
- 74
- 216
- Cash & Bank
- 20
- 30
- Total Assets
- 505
- Total Debt
- 10
- Net Working Capital
- 198
- Contingent Liabilities
- 25
- Book Value per Share
- 65.06
- Face Value
- 5.00
- Total Debt
- 10
- Net Working Capital
- 198
- Contingent Liabilities
- 25
- Book Value per Share
- 65.06
- Face Value
- 5.00
Mar 2026
- Equity Capital
- 50
- 302
- 0
- Trade Payables
- 188
- 14
- Total Liabilities
- 554
- 57
- Capital Work in Progress
- 0
- 84
- 148
- 239
- Cash & Bank
- 8
- 18
- Total Assets
- 554
- Total Debt
- 0
- Net Working Capital
- 248
- Contingent Liabilities
- 7
- Book Value per Share
- 35.14
- Face Value
- 5.00
- Total Debt
- 0
- Net Working Capital
- 248
- Contingent Liabilities
- 7
- Book Value per Share
- 35.14
- Face Value
- 5.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 2 | 7 | 49 | -19 | 29 | 54 | 13 | 37 | -3 | |
| Cash from Investing | -20 | 2 | 3 | -77 | 52 | -8 | -43 | 1 | -20 | 18 |
| Cash from Financing | -4 | -5 | -7 | 22 | -33 | -19 | -12 | -9 | -5 | -26 |
| 2 | -1 | 3 | -5 | 0 | 2 | -2 | 5 | 12 | -11 | |
| Free Cash Flow | 26 | -5 | -27 | 14 | -21 | 27 | 54 | 8 | 22 | -12 |
| OCF / Net Profit | 1.30 | 0.11 | 0.30 | 3.42 | -0.66 | 0.94 | 1.49 | 0.22 | 0.78 | -0.07 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -13 | -12 | 47 | 82 | 90 | 98 |
| OCF / Net Profit | 1.30 | 0.11 | 0.30 | 3.42 | -0.66 | 0.94 | 1.49 | 0.22 | 0.78 | -0.07 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -13 | -12 | 47 | 82 | 90 | 98 |
Mar 2017
- 26
- Cash from Investing
- -20
- Cash from Financing
- -4
- 2
- Free Cash Flow
- 26
- OCF / Net Profit
- 1.30
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.30
- Cumulative 5-Year FCF
- 0
Mar 2018
- 2
- Cash from Investing
- 2
- Cash from Financing
- -5
- -1
- Free Cash Flow
- -5
- OCF / Net Profit
- 0.11
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.11
- Cumulative 5-Year FCF
- 0
Mar 2019
- 7
- Cash from Investing
- 3
- Cash from Financing
- -7
- 3
- Free Cash Flow
- -27
- OCF / Net Profit
- 0.30
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.30
- Cumulative 5-Year FCF
- 0
Mar 2020
- 49
- Cash from Investing
- -77
- Cash from Financing
- 22
- -5
- Free Cash Flow
- 14
- OCF / Net Profit
- 3.42
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 3.42
- Cumulative 5-Year FCF
- 0
Mar 2021
- -19
- Cash from Investing
- 52
- Cash from Financing
- -33
- 0
- Free Cash Flow
- -21
- OCF / Net Profit
- -0.66
- Cumulative 5-Year FCF
- -13
- OCF / Net Profit
- -0.66
- Cumulative 5-Year FCF
- -13
Mar 2022
- 29
- Cash from Investing
- -8
- Cash from Financing
- -19
- 2
- Free Cash Flow
- 27
- OCF / Net Profit
- 0.94
- Cumulative 5-Year FCF
- -12
- OCF / Net Profit
- 0.94
- Cumulative 5-Year FCF
- -12
Mar 2023
- 54
- Cash from Investing
- -43
- Cash from Financing
- -12
- -2
- Free Cash Flow
- 54
- OCF / Net Profit
- 1.49
- Cumulative 5-Year FCF
- 47
- OCF / Net Profit
- 1.49
- Cumulative 5-Year FCF
- 47
Mar 2024
- 13
- Cash from Investing
- 1
- Cash from Financing
- -9
- 5
- Free Cash Flow
- 8
- OCF / Net Profit
- 0.22
- Cumulative 5-Year FCF
- 82
- OCF / Net Profit
- 0.22
- Cumulative 5-Year FCF
- 82
Mar 2025
- 37
- Cash from Investing
- -20
- Cash from Financing
- -5
- 12
- Free Cash Flow
- 22
- OCF / Net Profit
- 0.78
- Cumulative 5-Year FCF
- 90
- OCF / Net Profit
- 0.78
- Cumulative 5-Year FCF
- 90
Mar 2026
- -3
- Cash from Investing
- 18
- Cash from Financing
- -26
- -11
- Free Cash Flow
- -12
- OCF / Net Profit
- -0.07
- Cumulative 5-Year FCF
- 98
- OCF / Net Profit
- -0.07
- Cumulative 5-Year FCF
- 98
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 8.00 | 6.59 | 9.33 | 5.71 | 5.67 | 6.10 | 7.22 | 11.98 | 9.45 | 4.10 |
| Book Value (₹) | 56.09 | 59.71 | 65.69 | 64.74 | 38.04 | 42.66 | 48.14 | 58.11 | 65.06 | 35.14 |
| Dividend per Share (₹) | 2.50 | 2.75 | 2.75 | 2.75 | 1.50 | 1.75 | 2.00 | 2.50 | 1.50 | 1.50 |
| Cash EPS (₹) | 2.20 | 1.83 | 2.50 | 2.13 | 4.34 | 4.24 | 4.58 | 6.85 | 5.60 | 5.23 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 13.95% | 10.57% | 10.76% | 8.63% | 12.64% | 10.73% | 10.93% | 11.65% | 9.23% | 7.37% |
| Net Margin % | 9.24% | 6.79% | 7.25% | 4.50% | 6.46% | 6.22% | 6.83% | 9.24% | 7.10% | 5.27% |
| ROE % | 15.43% | 11.38% | 14.87% | 8.75% | 16.12% | 15.11% | 15.90% | 22.56% | 15.34% | 12.10% |
| ROCE % | 21.61% | 16.31% | 20.56% | 10.87% | 19.75% | 19.33% | 21.05% | 29.66% | 19.77% | 16.02% |
| 10.58% | 8.35% | 10.44% | 5.06% | 8.63% | 8.99% | 9.63% | 14.14% | 9.97% | 7.76% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 110 | 96 | 82 | 89 | 78 | 90 | 106 | 101 | 111 | 106 |
| Inventory Days | 45 | 46 | 42 | 60 | 59 | 60 | 53 | 42 | 41 | 52 |
| Payable Days | 115 | 96 | 84 | 131 | 125 | 117 | 125 | 111 | 109 | 105 |
| 40 | 46 | 41 | 19 | 12 | 33 | 33 | 32 | 43 | 53 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.00x | 0.02x | 0.03x | 0.27x | 0.07x | 0.01x | 0.00x | 0.01x | 0.03x | 0.00x |
| Interest Coverage (x) | 39.30x | 52.91x | 55.16x | 16.23x | 19.99x | 25.76x | 64.61x | 82.82x | 50.10x | 57.78x |
| 2.91x | 2.63x | 2.03x | 1.37x | 1.70x | 1.98x | 1.91x | 2.22x | 2.11x | 2.22x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -36.81% | 15.49% | 34.68% | -4.27% | 40.72% | 12.66% | 8.39% | 22.66% | 2.24% | 16.65% |
| Operating Profit Growth % | -26.27% | -15.11% | 34.87% | -20.82% | 102.79% | -5.38% | 9.98% | 51.68% | -19.20% | -6.24% |
| Net Profit Growth % | -22.30% | -17.65% | 41.51% | -38.78% | 98.78% | 7.47% | 18.38% | 66.00% | -21.16% | -13.32% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 66.00% | -21.16% | -56.66% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 10.25x | 7.88x | 16.39x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 4.23x | 2.29x | 1.91x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.02% | 1.01% | 2.23% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 13.94x | 10.38x | 9.98x |
Mar 2017
- EPS (₹)
- 8.00
- Book Value (₹)
- 56.09
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 2.20
- Operating Margin %
- 13.95%
- Net Margin %
- 9.24%
- ROE %
- 15.43%
- ROCE %
- 21.61%
- 10.58%
- Debtor Days
- 110
- Inventory Days
- 45
- Payable Days
- 115
- 40
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 39.30x
- 2.91x
- Revenue Growth %
- -36.81%
- Operating Profit Growth %
- -26.27%
- Net Profit Growth %
- -22.30%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 6.59
- Book Value (₹)
- 59.71
- Dividend per Share (₹)
- 2.75
- Cash EPS (₹)
- 1.83
- Operating Margin %
- 10.57%
- Net Margin %
- 6.79%
- ROE %
- 11.38%
- ROCE %
- 16.31%
- 8.35%
- Debtor Days
- 96
- Inventory Days
- 46
- Payable Days
- 96
- 46
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 52.91x
- 2.63x
- Revenue Growth %
- 15.49%
- Operating Profit Growth %
- -15.11%
- Net Profit Growth %
- -17.65%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 9.33
- Book Value (₹)
- 65.69
- Dividend per Share (₹)
- 2.75
- Cash EPS (₹)
- 2.50
- Operating Margin %
- 10.76%
- Net Margin %
- 7.25%
- ROE %
- 14.87%
- ROCE %
- 20.56%
- 10.44%
- Debtor Days
- 82
- Inventory Days
- 42
- Payable Days
- 84
- 41
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 55.16x
- 2.03x
- Revenue Growth %
- 34.68%
- Operating Profit Growth %
- 34.87%
- Net Profit Growth %
- 41.51%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 5.71
- Book Value (₹)
- 64.74
- Dividend per Share (₹)
- 2.75
- Cash EPS (₹)
- 2.13
- Operating Margin %
- 8.63%
- Net Margin %
- 4.50%
- ROE %
- 8.75%
- ROCE %
- 10.87%
- 5.06%
- Debtor Days
- 89
- Inventory Days
- 60
- Payable Days
- 131
- 19
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 16.23x
- 1.37x
- Revenue Growth %
- -4.27%
- Operating Profit Growth %
- -20.82%
- Net Profit Growth %
- -38.78%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 5.67
- Book Value (₹)
- 38.04
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 4.34
- Operating Margin %
- 12.64%
- Net Margin %
- 6.46%
- ROE %
- 16.12%
- ROCE %
- 19.75%
- 8.63%
- Debtor Days
- 78
- Inventory Days
- 59
- Payable Days
- 125
- 12
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 19.99x
- 1.70x
- Revenue Growth %
- 40.72%
- Operating Profit Growth %
- 102.79%
- Net Profit Growth %
- 98.78%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 6.10
- Book Value (₹)
- 42.66
- Dividend per Share (₹)
- 1.75
- Cash EPS (₹)
- 4.24
- Operating Margin %
- 10.73%
- Net Margin %
- 6.22%
- ROE %
- 15.11%
- ROCE %
- 19.33%
- 8.99%
- Debtor Days
- 90
- Inventory Days
- 60
- Payable Days
- 117
- 33
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 25.76x
- 1.98x
- Revenue Growth %
- 12.66%
- Operating Profit Growth %
- -5.38%
- Net Profit Growth %
- 7.47%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 7.22
- Book Value (₹)
- 48.14
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 4.58
- Operating Margin %
- 10.93%
- Net Margin %
- 6.83%
- ROE %
- 15.90%
- ROCE %
- 21.05%
- 9.63%
- Debtor Days
- 106
- Inventory Days
- 53
- Payable Days
- 125
- 33
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 64.61x
- 1.91x
- Revenue Growth %
- 8.39%
- Operating Profit Growth %
- 9.98%
- Net Profit Growth %
- 18.38%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 11.98
- Book Value (₹)
- 58.11
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 6.85
- Operating Margin %
- 11.65%
- Net Margin %
- 9.24%
- ROE %
- 22.56%
- ROCE %
- 29.66%
- 14.14%
- Debtor Days
- 101
- Inventory Days
- 42
- Payable Days
- 111
- 32
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 82.82x
- 2.22x
- Revenue Growth %
- 22.66%
- Operating Profit Growth %
- 51.68%
- Net Profit Growth %
- 66.00%
- 66.00%
- P/E (x)
- 10.25x
- P/B (x)
- 4.23x
- Dividend Yield %
- 1.02%
- 13.94x
Mar 2025
- EPS (₹)
- 9.45
- Book Value (₹)
- 65.06
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 5.60
- Operating Margin %
- 9.23%
- Net Margin %
- 7.10%
- ROE %
- 15.34%
- ROCE %
- 19.77%
- 9.97%
- Debtor Days
- 111
- Inventory Days
- 41
- Payable Days
- 109
- 43
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 50.10x
- 2.11x
- Revenue Growth %
- 2.24%
- Operating Profit Growth %
- -19.20%
- Net Profit Growth %
- -21.16%
- -21.16%
- P/E (x)
- 7.88x
- P/B (x)
- 2.29x
- Dividend Yield %
- 1.01%
- 10.38x
Mar 2026
- EPS (₹)
- 4.10
- Book Value (₹)
- 35.14
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 5.23
- Operating Margin %
- 7.37%
- Net Margin %
- 5.27%
- ROE %
- 12.10%
- ROCE %
- 16.02%
- 7.76%
- Debtor Days
- 106
- Inventory Days
- 52
- Payable Days
- 105
- 53
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 57.78x
- 2.22x
- Revenue Growth %
- 16.65%
- Operating Profit Growth %
- -6.24%
- Net Profit Growth %
- -13.32%
- -56.66%
- P/E (x)
- 16.39x
- P/B (x)
- 1.91x
- Dividend Yield %
- 2.23%
- 9.98x
Documents
Announcements
- Investor Presentation
2026-08-19 - Anuh Pharma Limited has informed the Exchange about Investor Presentation
- Change in Management
2026-08-14 - Anuh Pharma Limited has informed the Exchange about change in Management
Annual Reports
Credit Ratings
Nothing filed yet.